What is the Neuropsychiatric EEG-Based Assessment Aid (NEBA) System and how is it used in the diagnosis of pediatric attention deficit hyperactivity disorder (ADHD)?

Updated: Sep 09, 2021
  • Author: Maggie A Wilkes, MD; Chief Editor: Caroly Pataki, MD  more...
  • Print

In 2013, the Neuropsychiatric EEG-Based Assessment Aid (NEBA) System became the first FDA-approved, brain function–based medical device for use in the diagnosis of ADHD in children and adolescents aged 6-17 years. Although it is not meant to be used alone as a means of confirming the presence of ADHD, it can be employed in combination with a complete medical and psychological assessment to help confirm the diagnosis or to indicate the direction that further testing should take. Using electroencephalographic technology, the NEBA system calculates the ratio of theta and beta brain waves, which is comparatively high in children and adolescents with ADHD. [7, 8]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!